Fundz

Voyager Therapeutics Announces Appointment of Beth Shafer as Chief Business Officer

PUBLIC · VYGRAug 07, 2023

Position

Chief Business Officer

Company

Voyager Therapeutics

Beth Shafer
LexingtonBiotechnologyHealth CareTherapeutics

Description

CAMBRIDGE, Mass., Aug. 07, 2023 -- Voyager Therapeutics, Inc. , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of Beth Shafer, Ph.D., M.A., M.Phil., as Chief Business Officer

Quick answer

Voyager Therapeutics Announces Appointment of Beth Shafer as Chief Business Officer (August 7, 2023). Voyager Therapeutics is based in Lexington, Massachusetts, United States.

Who is the new Chief Business Officer at Voyager Therapeutics?
Voyager Therapeutics named Beth Shafer Chief Business Officer, announced August 7, 2023.
What did Voyager Therapeutics announce on August 7, 2023?
CAMBRIDGE, Mass., Aug. 07, 2023 -- Voyager Therapeutics, Inc. , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of Beth Shafer, Ph.D., M.A., M.Phil., as Chief Business Officer
What does Voyager Therapeutics do?
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases.
Where is Voyager Therapeutics based?
Voyager Therapeutics is based in Lexington, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
LumaBridge (August 8, 2023), XORTX Therapeutics (August 4, 2023), Apex Labs (August 10, 2023) and Deciphera Pharmaceuticals (August 3, 2023) also announced leadership changes within 45 days of Voyager Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Voyager Therapeutics, and when

A new leader at Voyager Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Voyager Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Voyager Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Voyager Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Voyager Therapeutics

Location

75 Hayden Avenue

Lexington, Massachusetts, United States

About

Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc.; and Sangamo Therapeutics, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Voyager Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mathieu
Likely contact at this company
••••••••@••••••••

See Mathieu's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Voyager Therapeutics's next move

Learn about Strategic plan

Voyager Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.